...We Welcome You to the Zenith Epigenetics Hub withIn The AGORACOM COMMUNITY!

Zenith's BET Inhibitor ZEN-3694 is Currently Being Evaluated in Multiple Oncology Clinical Trials

Free
Message: Re: ,Hong Kong exchange
3
Apr 26, 2018 06:10PM
2
Apr 27, 2018 12:09PM
1
Apr 27, 2018 12:16PM
3
Apr 28, 2018 12:12PM
2
Apr 29, 2018 08:59PM
2
Apr 30, 2018 09:57AM
3
Apr 30, 2018 10:42AM
3
May 01, 2018 04:54AM

hey,,,,tada,,that ***potential in its assets*** is that something likie the goodwill we see written off in so many takeovers??,,,, :o) ,,hahaha,,,,,just teasing,,,,but yes,,agreed its the market potential whether speculative or known that may get a price above what is generally perceived as a fair price!!,,,,,it maybe the only money maker for us in the end!!,,,and that is a big ol' speculative maybe!

If there was an epigeneric drug already approved by FDA or EDA or other our sledding would be much easier I assume.......!

Share
New Message
Please login to post a reply